flecainide has been researched along with Cardiac Diseases in 11 studies
Flecainide: A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
flecainide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid with the primary amino group of piperidin-2-ylmethylamine. An antiarrhythmic agent used (in the form of its acetate salt) to prevent and treat tachyarrhythmia (abnormal fast rhythm of the heart).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Unexplained cardiac arrest (UCA) can be caused by low-penetrance genetic disorders." | 1.42 | Diagnostic Approach to Unexplained Cardiac Arrest (from the FIVI-Gen Study). ( Álvarez, M; Cózar, R; Domingo, D; Fernández Pastor, J; Gimeno, JR; Grima, EZ; Heras, RP; Jiménez-Jáimez, J; Mazuelos, F; Monserrat, L; Moriña, P; Ortiz-Genga, M; Peinado, R; Sánchez Muñoz, JJ; Segura, F; Tercedor, L, 2015) |
| "Oral flecainide therapy was effective in 33 of 63 patients who had tachycardia and an extranodal accessory connection." | 1.28 | Safety and efficacy of oral flecainide therapy in patients with atrioventricular re-entrant tachycardia. ( Cockrell, JL; Griffin, JC; Helmy, I; Langberg, JJ; Lee, MA; Scheinman, MM; Titus, C, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (27.27) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bardien-Kruger, S | 1 |
| Wulff, H | 1 |
| Arieff, Z | 1 |
| Brink, P | 1 |
| Chandy, KG | 1 |
| Corfield, V | 1 |
| Jiménez-Jáimez, J | 1 |
| Peinado, R | 1 |
| Grima, EZ | 1 |
| Segura, F | 1 |
| Moriña, P | 1 |
| Sánchez Muñoz, JJ | 1 |
| Mazuelos, F | 1 |
| Cózar, R | 1 |
| Gimeno, JR | 1 |
| Heras, RP | 1 |
| Monserrat, L | 1 |
| Domingo, D | 1 |
| Ortiz-Genga, M | 1 |
| Fernández Pastor, J | 1 |
| Álvarez, M | 1 |
| Tercedor, L | 1 |
| Currie, S | 1 |
| Elliott, EB | 1 |
| Smith, GL | 1 |
| Loughrey, CM | 1 |
| Janko, S | 1 |
| Hoffmann, E | 1 |
| Conti, CR | 1 |
| Lombardi, F | 1 |
| Finocchiaro, ML | 1 |
| Dalla Vecchia, L | 1 |
| Rech, R | 1 |
| Castelli, A | 1 |
| Pastine, J | 1 |
| Cappiello, E | 1 |
| Vincenti, A | 1 |
| Landolina, M | 1 |
| Latini, R | 1 |
| Cavalli, A | 1 |
| Gaita, F | 1 |
| Giani, P | 1 |
| Cockrell, JL | 1 |
| Scheinman, MM | 1 |
| Titus, C | 1 |
| Helmy, I | 1 |
| Langberg, JJ | 1 |
| Lee, MA | 1 |
| Griffin, JC | 1 |
| Holtzman, JL | 1 |
| Weeks, CE | 1 |
| Kvam, DC | 1 |
| Berry, DA | 1 |
| Mottonen, L | 1 |
| Ekholm, BP | 1 |
| Chang, SF | 1 |
| Conard, GJ | 1 |
| Szatmáry, LJ | 1 |
| Bernadet, P | 1 |
| Puel, P | 1 |
| Nakamura, T | 1 |
| Nezuo, S | 1 |
| Hasegawa, K | 1 |
| Tadaoka, S | 1 |
| Nakao, M | 1 |
| Kakumae, S | 1 |
| Inoue, S | 1 |
| Kawahara, Y | 1 |
| Sawayama, T | 1 |
2 reviews available for flecainide and Cardiac Diseases
| Article | Year |
|---|---|
Two candidates at the heart of dysfunction: The ryanodine receptor and calcium/calmodulin protein kinase II as potential targets for therapeutic intervention-An in vivo perspective.
Topics: Animals; Anti-Arrhythmia Agents; Calcium; Calcium Channel Blockers; Calcium-Calmodulin-Dependent Pro | 2011 |
[Drug treatment of atrial fibrillation].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti | 2006 |
2 trials available for flecainide and Cardiac Diseases
| Article | Year |
|---|---|
Washout of long-term treatment with flecainide and propafenone in patients with complex ventricular arrhythmias and cardiac disease. Antiarrhythmic Drug Evaluation Group.
Topics: Arrhythmias, Cardiac; Electrocardiography; Flecainide; Heart Diseases; Humans; Male; Middle Aged; Pr | 1992 |
Identification of drug interactions by meta-analysis of premarketing trials: the effect of smoking on the pharmacokinetics and dosage requirements for flecainide acetate.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Female; Flecainide; Heart Diseases; Humans; Male; | 1989 |
7 other studies available for flecainide and Cardiac Diseases
| Article | Year |
|---|---|
Characterisation of the human voltage-gated potassium channel gene, KCNA7, a candidate gene for inherited cardiac disorders, and its exclusion as cause of progressive familial heart block I (PFHBI).
Topics: Amino Acid Sequence; Animals; Base Sequence; Cloning, Molecular; COS Cells; DNA; Heart Block; Heart | 2002 |
Diagnostic Approach to Unexplained Cardiac Arrest (from the FIVI-Gen Study).
Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Catheteri | 2015 |
What is structural heart disease?
Topics: Amiodarone; Anti-Arrhythmia Agents; Flecainide; Heart Diseases; Humans; Practice Patterns, Physician | 2000 |
Effects of mexiletine, propafenone and flecainide on signal-averaged electrocardiogram.
Topics: Adult; Aged; Aged, 80 and over; Electrocardiography, Ambulatory; Female; Flecainide; Heart Diseases; | 1992 |
Safety and efficacy of oral flecainide therapy in patients with atrioventricular re-entrant tachycardia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cardiac Pacing, Artificial; Child; Electric Stimulation; | 1991 |
Mechanical circulatory assistance in the management of patients in coronary care unit.
Topics: Adult; Aged; Aged, 80 and over; Angina, Unstable; Angioplasty, Balloon; Cardiac Surgical Procedures; | 1988 |
[Hemodynamic effects of flecainide in relation to its serum concentration].
Topics: Administration, Oral; Adolescent; Adult; Aged; Female; Flecainide; Heart Diseases; Hemodynamics; Hum | 1988 |